NetworkNewsBreaks – KemPharm Inc. (NASDAQ: KMPH) Announces $39M Warrant Exchange Offering
KemPharm (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, has announced its entry into agreements with certain of its holders of its existing warrants exercisable for 6,117,509 shares of its common stock, in the aggregate. According to the update, such holders have agreed to exercise their warrants for cash in exchange for the company’s agreement to issue in a private placement new warrants to purchase up to 1,529,379 shares of its common stock. The new warrants are exercisable immediately and have substantially the same terms as the existing warrants, except for the new…







